These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36937379)

  • 1. Nanotoxicology and Nanomedicine: The Yin and Yang of Nano-Bio Interactions for the New Decade.
    Bondarenko O; Mortimer M; Kahru A; Feliu N; Javed I; Kakinen A; Lin S; Xia T; Song Y; Davis TP; Lynch I; Parak WJ; Leong DT; Ke PC; Chen C; Zhao Y
    Nano Today; 2021 Aug; 39():. PubMed ID: 36937379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
    Nguyen NHA; Falagan-Lotsch P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives.
    Navya PN; Daima HK
    Nano Converg; 2016; 3(1):1. PubMed ID: 28191411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology.
    Chen C; Li YF; Qu Y; Chai Z; Zhao Y
    Chem Soc Rev; 2013 Nov; 42(21):8266-303. PubMed ID: 23868609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
    Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
    Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge gaps between nanotoxicological research and nanomaterial safety.
    Hu X; Li D; Gao Y; Mu L; Zhou Q
    Environ Int; 2016 Sep; 94():8-23. PubMed ID: 27203780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial Nano-Bio Interfaces.
    Cai P; Zhang X; Wang M; Wu YL; Chen X
    ACS Nano; 2018 Jun; 12(6):5078-5084. PubMed ID: 29883094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking nanomaterial properties to biological outcomes: analytical chemistry challenges in nanotoxicology for the next decade.
    Qiu TA; Clement PL; Haynes CL
    Chem Commun (Camb); 2018 Nov; 54(91):12787-12803. PubMed ID: 30357136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.
    Docter D; Strieth S; Westmeier D; Hayden O; Gao M; Knauer SK; Stauber RH
    Nanomedicine (Lond); 2015 Feb; 10(3):503-19. PubMed ID: 25707981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Nano-Bio Interactions and the Corresponding Biological Responses.
    Tian X; Chong Y; Ge C
    Front Chem; 2020; 8():446. PubMed ID: 32587847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein adsorption onto nanomaterials engineered for theranostic applications.
    Nienhaus K; Xue Y; Shang L; Nienhaus GU
    Nanotechnology; 2022 Apr; 33(26):. PubMed ID: 35294940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Safe-by-Design Strategy towards Safer Nanomaterials in Nanomedicines.
    Yan L; Zhao F; Wang J; Zu Y; Gu Z; Zhao Y
    Adv Mater; 2019 Nov; 31(45):e1805391. PubMed ID: 30701603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.
    Radomska A; Leszczyszyn J; Radomski MW
    Adv Clin Exp Med; 2016; 25(1):151-62. PubMed ID: 26935510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging Bio-Nano Science and Cancer Nanomedicine.
    Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
    ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular toxicity of nanomaterials.
    Chang XL; Yang ST; Xing G
    J Biomed Nanotechnol; 2014 Oct; 10(10):2828-51. PubMed ID: 25992420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.